Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
Conditions: Gastrointestinal Tumors; Colorectal Adenocarcinomas; Gastric Adenocarcinomas; Esophageal Adenocarcinomas Interventions: Drug: PF-07062119; Drug: Anti-PD1; Drug: Anti-VEGF Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials